European Surveillance of Antimicrobial Consumption (ESAC): Outpatient quinolone use in Europe (1997-2009)

Journal of Antimicrobial Chemotherapy

Volumn 66, Issue SUPPL. 6, 2011, Pages

  Adriaenssens, Niels ^a   Coenen, Samuel ^a   Versporten, Ann ^a   Muller, Arno ^a   Minalu, Girma ^b   Faes, Christel ^b   Vankerckhoven, Vanessa ^a   Aerts, Marc ^b   Hens, Niel ^a,b   Molenberghs, Geert ^b,c   Goossens, Herman ^a   Metz, Sigrid ^d   Fluch, Gerhard ^d   Vaerenberg, Sofie ^d   Goossens, Mathijs Michiel ^d   Markova, Boyka ^d   Andrašević, Arjana Tambic ^d   Kontemeniotis, Antonis ^d   Vlček, Jiří ^d   Frimodt Møller, Niels ^d   Jensen, Ulrich Stab ^d   Rootslane, Ly ^d   Laius, Ott ^d   Vuopio Varkila, Jaana ^d   Lyytikainen, Outi ^d   Cavalie, Philippe ^d   Kern, Winfried ^d   Giamarellou, Helen ^d   Antoniadou, Anastasia ^d   Ternák, Gábor ^d   Benko, Ria ^d   Briem, Haraldur ^d   Einarsson, Olafur ^d   Cunney, Robert ^d   Oza, Ajay ^d   Raz, Raul ^d   Edelstein, Hana ^d   Folino, Pietro ^d   Seilis, Andis ^d   Dumpis, Uga ^d   Valinteliene, Rolanda ^d   Bruch, Marcel ^d   Borg, Michael ^d   Zarb, Peter ^d   Natsch, Stephanie ^d   Kwint, Marieke ^d   Blix, Hege Salvesen ^d   Hryniewics, Waleria ^d   Olczak Pienkowska, Anna ^d   Kravanja, Malgorzata ^d   Ozorowski, Tomasz ^d   Ribeirinho, Mafalda ^d   Caldeira, Luis ^d   Bǎicus, Anda ^d   Popescu, Gabriel ^d   Ratchina, Svetlana ^d   Kozlov, Roman ^d   Foltán, Viliam ^d   Cižman, Milan ^d   Lázaro, Edurne ^d   Campos, José ^d   de Abajo, Francisco ^d   Dohnhammar, Ulrica ^d   Zanetti, Giorgio ^d   Davey, Peter ^d   Wickens, Hayley ^d   more..

^a UNIVERSITY OF ANTWERP   (Belgium)

^b HASSELT UNIVERSITY   (Belgium)

^c KU LEUVEN   (Belgium)

^d NONE

Author keywords

Ambulatory care; Antibiotic use; Drug consumption; Pharmacoepidemiology

Indexed keywords

CINOXACIN; CIPROFLOXACIN; ENOXACIN; FLEROXACIN; FLUMEQUINE; GARENOXACIN; GATIFLOXACIN; GEMIFLOXACIN; GREPAFLOXACIN; LEVOFLOXACIN; LOMEFLOXACIN; MOXIFLOXACIN; NALIDIXIC ACID; NORFLOXACIN; OXOLINIC ACID; PAZUFLOXACIN; PEFLOXACIN; PIPEMIDIC ACID; PIROMIDIC ACID; PRULIFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; ROSOXACIN; RUFLOXACIN; SPARFLOXACIN; TEMAFLOXACIN; TROVAFLOXACIN;

ARTICLE; DRUG USE; EUROPE; HUMAN; OUTPATIENT; SEASONAL VARIATION;

AMBULATORY CARE; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; DRUG UTILIZATION; EUROPE; HUMANS; OUTPATIENTS; PHARMACOEPIDEMIOLOGY; QUINOLONES; RESPIRATORY TRACT INFECTIONS; SEASONS; STATISTICS AS TOPIC;

EID: 82055183949     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkr457     Document Type: Article

References (22)

1. Ball P. Quinolone generations: natural history or natural selection? J Antimicrob Chemother 2000; 46: 17-24.
2. Ball P. Adverse drug reactions: implications for the development of fluoroquinolones. J Antimicrob Chemother 2000; 51: 21-7.
3. Hooper D. Fluoroquinolone resistance among Gram-positive cocci. Lancet Infect Dis 2002; 2: 530-9.
4. Adriaenssens N, Coenen S, Versporten A et al. European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe (1997-2009). J Antimicrob Chemother 2011; 66 Suppl 6: vi3-12.
5. WHO Collaborating Centre for Drug Statistics Methodology. Anatomical Therapeutic Chemical (ATC) Classification System: Guidelines for ATC Classification and DDD Assignment 2011. Oslo. www.whocc.no/ filearchive/publications/2011guidelines.pdf (26 October 2011, date last accessed).
6. Minalu G, Aerts M, Coenen S et al. Application of mixed-effects models to study the country-specific outpatient antibiotic use in Europe: a tutorial on longitudinal data analysis. J Antimicrob Chemother 2011; 66 Suppl 6: vi79-87.
7. Faes C, Molenberghs G, Hens N et al. Analysing the composition of outpatient antibiotic use: a tutorial on computational data analysis. J Antimicrob Chemother 2011; 66 Suppl 6: vi89-94.
8. Ferech M, Coenen S, Malhotra-Kumar S et al. European Surveillance of Antimicrobial Consumption (ESAC): outpatient quinolone use in Europe. J Antimicrob Chemother 2006; 58: 423-7.
9. Versporten A, Coenen S, Adriaenssens N et al. European Surveillance of Antimicrobial Consumption (ESAC): outpatient penicillin use in Europe (1997-2009). J Antimicrob Chemother 2011; 66 Suppl 6: vi13-23.
10. Versporten A, Coenen S, Adriaenssens N et al. European Surveillance of Antimicrobial Consumption (ESAC): outpatient cephalosporin use in Europe (1997-2009). J Antimicrob Chemother 2011; 66 Suppl 6: vi25-35.
11. Adriaenssens N, Coenen S, Versporten A et al. European Surveillance of Antimicrobial Consumption (ESAC): outpatient macrolide, lincosamide and streptogramin (MLS) use in Europe (1997-2009). J Antimicrob Chemother 2011; 66 Suppl 6: vi37-45.
12. Adriaenssens N, Coenen S, Versporten A et al. European Surveillance of Antimicrobial Consumption (ESAC): outpatient quinolone use in Europe (1997-2009). J Antimicrob Chemother 2011; 66 Suppl 6: vi47-56.
13. Coenen S, Adriaenssens N, Versporten A et al. European Surveillance of Antimicrobial Consumption (ESAC): outpatient use of tetracyclines, sulphonamides and trimethoprim, and other antibacterials in Europe (1997-2009). J Antimicrob Chemother 2011; 66 Suppl 6: vi57-70.
14. Wood F, Simpson S, Butler CC. Socially responsible antibiotic choices in primary care: a qualitative study of GPs' decisions to prescribe broad-spectrum and fluoroquinolone antibiotics. Fam Pract 2007; 24: 427-34.
15. Woodhead M, Blasi F, Ewig S et al. Guidelines for the management of adult lower respiratory tract infections. Eur Respir J 2005; 26: 1138-80.
16. Mills GD, Oehley MR, Arrol B. Effectiveness of b lactam antibiotics compared with antibiotics active against atypical pathogens in non-severe community acquired pneumonia: meta-analysis. BMJ 2005; 330: 456-62.
17. Ho PL, Yung RWH, Tsang DNC et al. Increasing resistance of Streptococcus pneumoniae to fluoroquinolones: results of a Hong Kong multicentre study in 2000. J Antimicrob Chemother 2001; 48: 659-65.
18. Coenen S, Ferech M, Haaijer-Ruskamp FM et al. European Surveillance of Antimicrobial Consumption (ESAC): quality indicators for outpatient antibiotic use in Europe. Qual Saf Health Care 2007; 16: 440-5.
19. Adriaenssens N, Coenen S, Versporten A et al. European Surveillance of Antimicrobial Consumption (ESAC): quality appraisal of antibiotic use in Europe. J Antimicrob Chemother 2011; 66 Suppl 6: vi71-7.
20. Adriaenssens N, Coenen S, Tonkin-Crine S et al. European Surveillance of Antimicrobial Consumption (ESAC): disease-specific quality indicators for outpatient antibiotic prescribing. BMJ Qual Saf 2011; 20: 764-72.
21. Altiner A, Wilm S, Wegscheider K et al. Fluoroquinolones to treat uncomplicated acute cough in primary care: predictors for unjustified prescribing of antibiotics. J Antimicrob Chemother 2010; 65: 1521-5.
22. McGuire M, Keel A, Scott B. A revised framework for national surveillance of healthcare associated infection and the introduction of a new health efficiency and access to treatment (HEAT) target for Clostridium difficile associated disease (CDAD) for NHS Scotland. www.sehd.scot.nhs.uk/mels/CEL2009_11.pdf (26 October 2011, date last accessed).